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Abstract
Background: Commercial Atlantic salmon is fed diets with high fat levels to promote fast and cost-effective
growth. To avoid negative impact of obesity, food additives that stimulate fat metabolism and immune function
are of high interest. TTA, tetradecylthioacetic acid, is a synthetic fatty acid that stimulates mitochondrial b-oxidation
most likely by activation of peroxysome proliferator-activated receptors (PPARs). PPARs are important transcription
factors regulating multiple functions including fat metabolism and immune responses. Atlantic salmon experiments
have shown that TTA supplemented diets significantly reduce mortality during natural outbreaks of viral diseases,
suggesting a modulatory role of the immune system.
Results: To gain new insights into TTA effects on the Atlantic salmon immune system, a factorial, high-throughput
microarray experiment was conducted using a 44K oligo nucleotide salmon microarray SIQ2.0 and the Atlantic
salmon macrophage-like cell line ASK. The experiment was used to determine the transcriptional effects of TTA, the
effects of TTA in poly(I:C) elicited cells and the effects of pretreating the cells with TTA. The expression patterns
revealed that a large proportion of genes regulated by TTA were related to lipid metabolism and increased
mitochondrial b-oxidation. In addition we found that for a subset of genes TTA antagonized the transcriptional
effects of poly(I:C). This, together with the results from qRT-PCR showing an increased transcription of anti-
inflammatory IL10 by TTA, indicates anti-inflammatory effects.
Conclusions: We demonstrate that TTA has significant effects on macrophage-like salmon cells that are challenged
by the artificial dsRNA poly(I:C). The immune stimulatory effect of TTA in macrophages involves increased lipid
metabolism and suppressed inflammatory status. Thus, suggesting that TTA directs the macrophage-like cells
towards alternative, anti-inflammatory, activation. This has positive implications for TTA as a feed additive.
Background
In commercial Atlantic salmon (Salmo salar L.) aqua-
culture, diets usually contain high levels of fat as it pro-
vides an inexpensive source of energy and promotes
rapid growth. However, high levels of dietary fat cause
excess fat to be deposited in the tissues, most notably in
muscle, liver and as visceral fat [1]. Thereby the diet
may affect the general health of the Atlantic salmon and
also the quality of the filet as the final product [2]. In
order to reduce the negative side effects of high fat
diets, several studies have experimented with food addi-
tives promoting fat catabolism. Tetradecylthioacetic acid
(TTA) is one of these additives, considered to be highly
interesting.
TTA is a synthetic fatty acid with a sulfur substitution
at the 3rd position in the carbon chain. The chemical
properties of TTA resemble those of a normal fatty acid
of similar length. What makes TTA interesting is that
the sulfur atom makes it resistant towards further cata-
bolism via b-oxidation and that TTA serves as activator
for all peroxysome proliferator-activated receptor
(PPAR) subtypes [3,4]. PPARs are important transcrip-
tion factors regulating multiple functions, most notably
fat metabolism and immune responses (reviewed in [5]).
TTA has been reported to induce pleiotropic effects in
mammals. These effects include increased mitochondrial
b-oxidation in muscle and liver, decreased plasma lipid
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e f f e c t s( r e v i e w e di n[ 6 , 7 ] ) .I ta p p e a r st h a tm o s to ft h e
metabolic effects of TTA are mediated through activa-
tion of PPARs.
Studies addressing metabolic effects of TTA in fish are
scarce. Nevertheless, the studies that have been con-
ducted with members of the salmonidae family indicate
similar metabolic effects of TTA in fish by showing
increased lipid metabolism in liver [8,9] and muscle
[10]. In contrast to mammals, high levels of dietary
TTA have been reported to induce mortality in Atlantic
salmon [9,11] but not in Rainbow trout (Oncorhynchus
mykiss Walbaum) [8]. It has been hypothesized that the
mortality may be related to accumulation of TTA-meta-
bolites in the kidney at low temperatures [12].
To date only one study investigated immune modula-
tory functions of TTA in Atlantic salmon, showing that
TTA reduces the production of leukotriene B4 (LTB4)
and prostaglandin E2 (PGE2) in headkidney macrophages
isolated from TTA fed fish [12]. It should be noted that
the reduction was found only to be significant for cells
cultured at 5°C, but not in those maintained at 12°C
[12]. Intriguingly, two studies, both reporting significant
reduced mortality in Atlantic salmon pre fed with a
low-level TTA supplemented diet during natural out-
breaks of viral diseases in sea [10,13], indicate important
immune modulatory effects of TTA. Hence, TTA may
be of interest as a feed additive in Atlantic salmon
aquaculture.
To address immune modulatory functions of TTA in
Atlantic salmon we conducted a “genome wide” micro-
array approach in a factorial designed experiment to
identify transcriptional effects of TTA using the estab-
lished, macrophage-like cell line ASK [14]. The cell line
was chosen because macrophages pose a key role in the
innate immunity, which is considered to be of primary
importance to fight off pathogens since it can take
weeks to mount an acquired immune response in poiki-
lothermic fish [15]. Macrophages posses a remarkable
plasticity that allows them to change their phenotype
according to environmental signals. In vitro two major
macrophage phenotypes have been characterized. Classi-
cally activated macrophages displaying a pro-inflamma-
tory profile and alternative activated macrophages
showing anti-inflammatory properties [16]. Macrophages
recognize invading pathogens via pattern recognition
receptors that bind conserved pathogen-associated
molecular patterns (PAMPs). Activation of macrophages
via PAMPs induces the classical activated phenotype.
Because most viral pathogens produce dsRNA during
one part of their replication [17], we decided to use the
double stranded RNA analogue poly(I:C), a frequently
used PAMP to simulate infection with a viral pathogen
in our experiment.
A large proportion of the genes regulated by TTA was
related to increased lipid metabolism and were also acti-
vated by TTA in poly(I:C) elicited ASK cells. The main
effect seen for TTA in poly(I:C) elicited cells was to
antagonize the induction of a subset of poly(I:C) depen-
dent genes. Further we found increased expression of
anti-inflammatory IL10 and Krueppel-like factor 11
(KLF11). Thus the results indicate that TTA polarizes
the macrophage-like cells towards the alternative acti-
vated state.
Results
We used the permanent Atlantic salmon macrophage-
like cell line ASK in a factorial designed experiment to
study transcriptional effects of TTA. An overview of the
experimental design is given in Table 1. RNA from two
biological replicates was used in the microarray analysis
with the Atlantic salmon SIQ2.0 microarray [18] in a
one-color setup, resulting in totally 16 arrays. One array
did not pass the quality control analysis and was subse-
quently excluded from the final data set (Table 1, indi-
cated by*). To identify differentially expressed (DE)
probes, a linear model (Equation 2), containing the
main effects was fitted to each probe set. Subsequently
we extracted specific contrasts (Table 2), using the Bio-
conductor package “limma” [19].
Pretreatment with TTA (preTTA vs. CTR) significantly
altered the expression of 121p r o b e s( 1 0 8g e n e s ) ,w h i l e
treatment with TTA (TTA vs. CTR) affected 49 probes
(41 genes) (Table 3). Stimulating the cells with poly(I:C)
showed the strongest effect with regard to number of
DE probes and log2FC with 3636 DE probes (2785
genes) in the contrast IC vs. CTR. We observed signifi-
cant alteration of 3487 probes (2697 genes) when treat-
ing the cells with TTA and poly(I:C) simultaneously
(TTAIC vs. CTR). 92 probes (70 genes) were DE when
comparing the concordant TTA and poly(I:C) treatment
vs. poly(I:C) treatment (IC vs. TTAIC), indicating that
Table 1 Experimental design
Pretreatment Treatment biol. repl.
a array
b
Control Control 4 2
TTA 4 2
TTA+poly(I:C) 4 2
poly(I:C) 4 2
TTA Control 4 2
TTA 4 2
TTA+poly(I:C) 4 2
poly(I:C) 4 2*
a Replicates, using different passages of the cells
b Number of replicates used in the array experiment
* One of the arrays did not pass the quality control and was excluded from
further analysis
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lenged cells.
In this study we were primarily interested in transcrip-
tional effects related to TTA. Thus, we will focus for the
rest of the paper on the three TTA related contrasts:
preTTA vs. CTR, TTA vs. CTR and IC vs. TTAIC.H o w -
ever, a comprehensive list of all DE probes for each con-
trast can be found in Additional file 1, Table S1.
The number of DE probes and their overlap between
the different contrasts is shown in Figure 1.
Transcriptional effects in IC vs. TTAIC
92 probes were DE when comparing ASK cells treated
with poly(I:C) alone vs. cells that received concordant
TTA and poly(I:C) treatment (Figure 1 and 2). Consid-
ering that poly(I:C) treatment alone significantly altered
the expression of 3636 probes (Figure 1), the effects of
TTA under poly(I:C) elicitation may be considered rela-
tively small.
We observed that after hierarchical clustering of the
DE probes for the IC vs. TTAIC contrast the genes
could be separated into three major clusters (Figure 2).
First, probes showing mostly a moderate down-regula-
tion in response to poly(I:C), but a generally stronger
down-regulation upon concordant TTA poly(I:C) treat-
ment (cluster.1). Second, probes that were up-regulated
by TTA, but down-regulated by poly(I:C) treatment
(cluster.2). And third, probes that were less up-regulated
when treated with TTA in combination with poly(I:C)
(cluster.3). Especially for the second and the third clus-
ter of probes we observed profound antagonistic effects
for TTA in poly(I:C) elicited macrophages.
We found that cluster.2 contained mostly genes that
w e r er e l a t e dt of a tm e t a b o l i s m ,a n dt h a tm o s to ft h e m
were shared with the TTA vs CTR contrast (see next
section). Genes of particular interest were: ANGPTL4,a s
the highest ranking gene, Acadm, AGPAT4, THIM,
HADHA, PLIN2 and KLF11. Angiopoetin-related protein
4 (ANGPTL4) has been reported, beside having a role
in regulating angiogenesis, to act as a important stimula-
tor of lipid metabolism [20]. Acetyl-CoA acyltransferase
THIM and the mitochondrial trifunctional enzyme
HADHA are enzymes of the mitochondrial b-oxidation.
The gene AGPAT4 encodes an acyltransferase, partici-
pating in de-novo phospholipid synthesis. The gene
remains yet to be fully characterized, however, other iso-
forms have been reported to be regulated by PPAR-a
[21]. The protein Perilipin 2 (PLIN2) is a lipid droplet
associated protein, recently suggested to stimulate
Table 2 Specific contrasts
Contrast H0 to test Interpretation when H0 is rejected and the corresponding log2FC passes the cut-off
preTTA vs. CTR H0 : PTTA = Pcontr DE in: Samples pretreated with TTA vs. pretreatment Control
TTA vs. CTR H0 : TTTA = Tcontr DE in: Samples treated with TTA vs. Control treated
TTAIC vs. CTR H0 : TTTA+polyI:C = Tcontr DE in: Samples treated with TTA+poly(I:C) vs. Control treated
IC vs. CTR H0 : TpolyI:C = Tcontr DE in: Samples treated with poly(I:C) vs. Control treated
IC vs. TTAIC H0 : TTTA+polyI:C = TpolyI:C DE in: Samples treated with TTA+poly(I:C) vs. poly(I:C) treated
Contrasts, extracted for each probe after the full linear model (Equation 2) was fitted to the data.
Table 3 Summary of significant probes identified by the
different contrasts
Contrast UP/DOWN Probes Probes
(lfc >1)
Probes
(lfc >2)
Pretreatment
preTTA vs. CTR UP 119 4 0
DOWN 2 0 0
Treatment
TTA vs. CTR UP 27 6 0
DOWN 22 1 0
TTAIC vs. CTR UP 1043 476 250
DOWN 2444 764 72
IC vs. CTR UP 1491 594 227
DOWN 2145 787 80
IC vs. TTAIC UP 22 4 0
DOWN 70 9 0
preTTA vs CTR
TTA vs CTR
IC vs CTR
TTAIC vs CTR
IC vs TTAIC
69 2985
30 18 30
46
38 81 1 39
3636
92
49
3487
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Figure 1 Overlap matrix. Overlap of the DE probes between the
different contrasts. The numbers within cells display the number of
common probes, while the red numbers in the diagonal display the
total number of DE probes in that contrast.
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Figure 2 Heatmaps. Heatmaps displaying the relative expression of the probes significant in the three TTA related contrasts (IC vs. TTAIC, TTA vs.
CTR and preTTA vs. CTR. The probes were clustered hierarchical using euclidean distance as indicated by the dendrogram on the side. The color
code attached to the dendrogram indicates overlap for the corresponding gene between the 3 contrasts. In the dendrogram of the heatmap for
contrast IC vs. TTAIC, the three major clusters are highlighted additionally (lightgrey - cluster.1; grey - cluster.2; darkgrey - cluster.3).
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Page 4 of 13lipolysis in macrophages [22]. Moreover, KLF11 an inhi-
bitor of cellular PGE2 synthesis [23] and APOEB, the
teleost homolog to apoE, was found to be strongly up-
regulated. PGE2 is an important mediator of inflamma-
tion and has been previously reported to be down-regu-
lated in response to TTA treatment [12,24]. ApoE
secreted by macrophages participates in the regulation
of cholesterol efflux, reducing the cholesterol-ester accu-
mulation in macrophages attached to the arterial wall
[25]. In addition, ApoE in macrophages has been
reported to act as suppressor of pro-inflammatory sig-
nals and vice versa [26], and is reported to respond to
PPAR-g agonists in macrophages [27]. Hence, these
results suggest that TTA induces lipid metabolism and
also affects lipid mediators of inflammation in poly(I:C)
elicited macrophages.
The genes in cluster.1 and cluster.3, down-regulated
for the IC vs. TTAIC contrast, contained several genes
with reported functions in immune modulation. The
genes encoding Nattectin (NATTE) and Lysozyme G
(LYG) both showed a strong increase in transcription in
response to poly(I:C), which was attenuated when TTA
was added. Nattectin has been identified as C-type lectin
in fish [28]. C-type lectins function as pattern recogni-
tion receptors, recognizing pathogens and may subse-
quently opsonize them for phagocytosis. C-type lectins
are induced following infection with bacterial [29] and
viral [30] pathogens in fish, hence, suggesting host
defense properties. Lysozyme is primarily associated
with the defense against bacterial pathogens through
hydrolyzing b1,4 glycoside bounds of peptidoglucans in
the bacterial cell wall [31]. Expression of the anti-
inflammatory marker Pituitary adenylate cyclase-activat-
ing polypeptide (PACA) [32], was strongly decreased in
the IC vs. CTR contrast, but showed increased expres-
sion in the IC vs. TTAIC contrast. A similar pattern was
observed for Os-teoprotegerin (TNFRSF11B). Osteopro-
tegerin is a member of the tumor necrosis receptor
superfamily. Initially Osteoprotegrin was characterized
for its ability to suppress osteoclast formation [33].
However Osteoprotegrin has also been reported to have
a role in controlling inflammation. Exposure of mamma-
lian endothelial cells to inflammatory cytokines has been
reported to increase Osteoprotegrin expression, which
in turn promotes leucocyte adhesion in vitro and in vivo
[34].
Transcriptional effects in TTA vs. CTR
49 probes were DE in response to treatment with TTA
(Figure 1, Figure 2). From these 49 probes we found 27
to be up- and 22 probes to be down-regulated. The
transcriptional changes in general were modest, with 6
probes showing an absolute log2FC ≥ 1( T a b l e3 ) .A s
shown in Figure 1 (and indicated in the dendrogram of
Figure 2) the overlap to the previously described IC vs.
TTAIC contrast was 37%, demonstrating that TTA
affects a slightly different subsets of genes when applied
alone to ASK cells.
Treatment with TTA generally increased the expres-
sion of genes involved in lipid metabolism. The gene
showing the highest log2FC in this contrast was Angio-
poetin-related protein 4 (ANGPTL4). Further we found a
couple of genes encoding crucial enzymes for mitochon-
drial b-oxidation. We found carnitine palmitoyltransfer-
ase 1A (Cpt1a), the acyl-CoA dehydrogenase (ACADM )
and mitochondrial trifunctional enzyme (HADHB)t ob e
up-regulated. Also we observed increased expression of
the gene encoding the lipid particle associated protein
PLIN2 and short-chain dehydrogenase/reductase
DHRS3. Thus, indicating increased lipid metabolism in
ASK cells following TTA treatment.
We observed TTA regulation of a number of genes
associated to anti-inflammatory effects. The second
highest ranking gene up-regulated was the PGE2 inhibi-
tor KLF11 [23]. Moreover we observed attenuated tran-
scription of Grannulins (GRN )/progrannulin and the
neuropeptide pituitary adenylate cyclase-activating poly-
peptide (PACA). Both genes are reported to exhibit anti-
inflammatory effects. Macrophages isolated from mice
deficient for the Grannulin gene showed higher tran-
scription levels of pro-inflammatory cytokines [35], indi-
cating an anti-inflammatory role for progrannulin.
PACA has been identified to exert anti-inflammatory
effects [32]. Increased expression of the matrix metallo-
proteinases MMP3, MMP13 and chemokine ligand 2
(CXCL2) was found in TTA treated ASK cells. Matrix
metalloproteinases (MMPs) possess pleiotropic functions
such as acting as matrix degrading enzymes, immuno-
modulary functions and have been suggested to be
required for the migration of inflammatory cells [36].
CXCL2 has been implicated to act as chemotactic or
activating factor for monocytes [37] and was further
found to be highly induced by poly(I:C) treatment. Thus
suggesting an increased potential for cell migration
induced by TTA.
Further, megakaryocyte-associated tyrosine kinase
(MATK ) and the transcription factor AP-1 (JUN )
proofed to be down-regulated. MATK is a nonreceptor
tyrosine kinase that negatively regulates the activity of
the Src family protein kinases - key regulators in signal
transduction. A study showed higher levels of inter-
feron-g in MATK K.O mice challenged with antigens,
thus suggesting a function for MATK in the immunolo-
gical response [38]. JUN is an important transcription
factor responding to cytokines and stress and has been
reported to be up-regulated in response to viral chal-
lenges in Atlantic salmon [39,40]. Further we found a
decreased expression of NPTX2, a member of the
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recognition receptors and can facilitate pathogen recog-
nition and removal [15].
Transcriptional effects in preTTA vs. CTR
In the two experiments showing lower mortality in
Atlantic salmon fed with TTA upon natural (viral) dis-
ease outbreak, the TTA feeding period ended before the
onset of disease related mortality [10,13]. So we specu-
lated that TTA might have long-term effects on the
immunity in Atlantic salmon. To identify these effects
we included the factor pretreatment in the experimental
design. We found that pretreatment with TTA caused
DE of 121 probes, which with the exception of two
probes, all showed increased transcription (Table 3).
The list of DE probes showed relatively little overlap
with the two previously described TTA contrasts (7%
and 9% to the contrasts IC vs. TTAIC and TTA vs. CTR
respectively, Figure 2). Hence, suggesting that TTA pre-
treatment affects a different subset of genes. However,
38 of the probes in this contrast were also DE in the
contrast IC vs. CTR (Figure 1). It should be noted that,
similar to the effects observed in IC vs. TTAIC, the gene
regulation in response to TTA pretreatment was mostly
antagonistic to the effect found in IC vs. CTR (Figure 3).
Fatty acid metabolism and anti-inflammatory gene
expression were less affected by pretreatment compared
to treatment with TTA. The two fat metabolism related
genes ANGPTL4 and elongation of very long chain fatty
acids protein 2 (ELOV2 ) were both up-regulated.
Further we observed increased transcription of Interleu-
kin 17 D (IL17D). The IL 17 family possesses an essen-
tial role in protecting the host from infection by
pathogens [41]. The anti-inflammatory gene PACA and
the pattern recognition receptor NPTX2, both described
in the previous contrasts showed increased gene expres-
sion. It should be noted that the gene regulation of
NPTX2 in preTTA vs. CTR was opposite to that found
in TTA vs CTR. Two transmembrane proteins, Integrin
b 5 (ITB5) and thrombospondin-4 (thbs4b), both contri-
buting to cell adhesion and migration showed increased
transcription following pre-treatment with TTA. In
addition we found increased expression of the trans-
membrane receptors roundabout-1 (ROBO1) and plexin-
C1 (PLXNC1). Both receptors are considered to be
repulsive receptors, contributing to the release of cell
adhesion upon ligand activation [42,43]. These results
may indicate that pretreatement with TTA supports
increased cell migration in ASK cells, similar to the
effects found in TTA vs. CTR.
Approximately 10% of the genes DE following TTA
pre-treatment were transporters/ion channels. The
genes included the GABA transporter (SLC6A13), Na
+/dicarboxylate co-transporter (SLC13A2), SLC22A15b,
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Figure 3 qRT PCR verification. Comparison of the log2 fold changes and the estimated significances between qRT-PCR (n = 4) and array (n =
2). Significances for the different contrasts were estimated by linear models for the array (as described in Methods) and 1-way ANOVA
(Equation.1) followed by a Tukey test for qRT-PCR. Before calculating the fold changes the qRT-PCR expression values were normalized to the
expression of the housekeeping gene Elongation factor 1a (EF1a). Contrasts found to be significant are marked with an asterisk. ACDAM: acyl-
Coenzyme A dehydrogenase, medium-chain; ANGPTL4: Angiopoetin-like protein 4; hsp70: Heat shock protein 70; SLC6A13: Solute carrier family
6 member 13/sodium- and chloride-dependent GABA transporter 2; TLR3: Toll-like receptor 3; UBA1: ubiquitin-like modifier activating enzyme 1.
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- transporter (CLCN5), v-type proton
ATPase subunit s1 (ATP6AP1), ATP2A1, K-channel
(KCNQ5), the neurotransmitter-gated ion channel
GLRB and the Ca
2+ activated chloride channel TTYH3
as the only one showing down-regulation. CLCN5 and
ATP6AP1 are responsible for the acidification of the
endosomal lumen. Hence, the increased expression sug-
gests a higher capacity for acidification of the endosome,
which may promote phagocytosis [44].
qRT-PCR
To validate the microarray results, six genes were ran-
domly chosen from the list of DE genes for all con-
trasts. The genes were analyzed by qRT-PCR (Figure
4). In four cases we were able to detect significance by
qRT-PCR, but not by array. However, in these cases
the log2FC proofed to be lower than the cut-off of 0.5,
that we used to identify significant genes in the array
experiment. In one case we detected significance by
array, but could not confirm this by qRT-PCR. Overall
the results indicate that the parameters chosen to
account for multiple hypothesis testing were appropri-
ate. The results of the log2FCs for qRT-PCR matched
those obtained by array. When comparing the log2FCs
obtained for all genes and contrasts between qRT-PCR
and array we found a highly significant correlation
(pearson correlation of r = 0.96, p = 2.2e
-16 and an
R
2 = 0.92).
To further study immune modulatory effects of TTA
in ASK cells, we used qRT-PCR to measure the expres-
sion of selected genes previously reported to respond
directly to TTA or other PPAR agonists (Cox2, IL10,
PPARg, TNFa, Arg1) and/or are important mediators of
inflammation (IL1b, IFa(1+2), Mx)( F i g u r e4 ) .N o n eo f
the analyzed genes was found to respond significantly to
the effect of pretreatment with TTA. Several genes,
however, responded significantly to the four different
treatments.
For Interleukin 10 (IL10), which is generally consid-
ered to have anti-inflammatory properties, we found sig-
nificant lower expression in the group that received poly
(I:C), compared to all other treatment groups. The two
pro-inflammatory cytokines TNFa and Interferon a
showed no DE in response to the different treatments.
It should be noted that the expression of TNFa could
only be detected in poly(I:C) elicited samples and that
concordant application of TTA and poly(I:C) reduced
the mean expression by 50%. PPARg showed no altered
expression in response to the different treatments. Argi-
nase 1 was significantly higher expressed in all samples
that received poly(I:C) treatment, additionally we
observed that TTA also increased the Arginase 1
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Figure 4 qRT-PCR. Box plots showing log2 gene expression relative to the mean expression of the samples that received control pretreatment
and control treatment. Gene expression was normalized to the expression of the housekeeping gene EF1a. Significance was assessed using 1-
way ANOVA (Equation.1). None of the tested genes was significant affected by TTA pretreatment. Different letters between the box plots
indicate significant difference between the treatments, as determined by Tukey test (p-value ≤ 0.05, n = 4). Mx: myxovirus resistance 1; Cox2:
Cyclooxygease 2; Arg1: Arginase 1; PPARg: peroxysome proliferator-activated receptor g ; TNFa: Tumor necrosis factor a (1+2); IFa1+2:
Interferon a (1+2); IL10: Interleukin 10; IL1b: Interleukin 1b* Reliable gene expression could be only measured for samples that received poly IC
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Grammes and Takle BMC Immunology 2011, 12:41
http://www.biomedcentral.com/1471-2172/12/41
Page 7 of 13expression. The mean expression of the samples receiv-
ing TTA and poly(I:C) was 67% higher compared to the
poly(I:C) samples. Even though not statistical significant,
we observed a reduction in the expression of COX2
upon TTA treatment. Interleukin 1b is considered to be
pro-inflammatory. We found a significant increase in
transcription upon poly(I:C) elicitation, while concor-
dant treatment with TTA and poly(I:C) elevated the
mean expression (not significant). Mx is considered to
be an antiviral protein [45], TTA treatment caused a
significant reduction of Mx gene expression. Treatment
with poly(I:C) increased the expression strongly.
Discussion
In the present study we characterized the transcriptional
responses to the PPAR activator TTA in the Atlantic sal-
mon macrophage-like ASK cell line. Considering the
strong effects documented for various PPAR agonists in
different tissues like intestine or fat tissue (reviewed [46])
we found relatively few genes responding with altered
transcription to TTA treatment. However, based on the
results of the Microarray and qRT-PCR analysis TTA
was found to stimulate the capacity for fat metabolism
and have anti-inflammtory effects in the ASK cell line.
T h ei n n a t ei m m u n er e s p o n s er e c o g n i z e si n v a d i n g
pathogens by pattern recognition receptors (PRR)
through recognition of pathogen-associated molecular
patterns. Toll-like receptor sa r eaf a m i l yo fP R R sw h e r e
each receptor displays specificity for it’s lig-and [47].
Viral pathogens produce double stranded (ds) RNA dur-
ing one part of their reproduction cycle. DsRNA is
recognized by TLR3, triggering the production and
release of pro-inflammatory cytokines [48]. The results
from our microarray study showed that indeed a high
number of genes were DE in poly(I:C) elicited macro-
phages. By comparing the group that received concor-
dant treatment with TTA and poly(I:C) against the
group that received poly(I:C) alone we identified a sub-
set of genes showing antagonistic regulation. Several of
these genes were sparsely characterized in the literature,
especially in relation to immune function. However, the
fact that we found those genes to be induced by poly(I:
C) suggests a function in the Atlantic salmon immune
response. Indicating that application of TTA to Atlantic
salmon ASK cells has immune modulatory properties.
Expression of anti-inflammatory markers by macro-
phages is a hallmark for the alternative activated state.
Anti-inflammatory effects of TTA have been mainly
ascribed to increased expression of anti-inflammatory
IL10. Indeed, we found a significant 98% increased tran-
scription of IL10. Hence, indicating that TTA increases
expression of IL10 in poly(I:C) activated macrophages,
similar to the effects reported from human PBMCs sti-
mulated with TTA [49,50].
Further we identified the PGE2 inhibitor KLF11 [23]
as up-regulated in response to TTA. PGE2 is a mediator
of inflammation, produced from PGH2 which is mainly
produced by COX2. We observed that in poly(I:C) eli-
cited ASK cells, TTA caused a mean reduction of 24%
in COX2 gene expression. Arguably, these results indi-
cate that TTA attenuates the capacity for production of
pro-inflammatory PGE2, as it has been shown in pri-
mary macrophages from TTA fed fish reared at 5°C, but
not for those kept at 12°C [12].
Arg1 competes with iNOS, an enzyme controlling the
production of Nitric oxide for it’s substrate. Arg1 is con-
sidered to be a key marker for alternative activated
macrophages [51]. Recent studies in mice have shown
that the expression of Arg1 in alternative activated
macrophages is essential for suppressing inflammation
[52]. Thus, our observation that TTA increased the
expression of Arg1 by 67%, supports anti-inflammatory
effects of TTA, and is also in accordance with a
described regulation of Arg1 expression by PPAR-g and
b/δ [51]. Studies conducted on murine macrophages
have shown that an up-regulation in fatty acid oxidation
is crucial to direct them towards an alternative activated
state [53]. In agreement with this we found that TTA
induced the expression of genes that are related to lipid
metabolism in ASK cells. Namely we identified
increased expression of Angiopoetin-like protein 4
(ANGPTL4), carnitine palmitoyltransferase 1 (Cpt1a),
acyl-CoA dehydrogenase (Acdam), enoyl-Coenzyme A
hydratase (HADH) and the lipid droplet associated pro-
tein PLIN2. These effects of TTA are also consistent
with reports of increased fatty acid oxidation upon TTA
treatment [6,8] and also with effects associated to PPAR
activation [5]. Taken together, the results provided by
this study indicate that TTA directs the macrophage-
like ASK cells towards an anti-inflammational, alterna-
tive activated state. Studies conducted in mice have
reported that macrophages in the alternative activated
state, via macrophage-parenchymal cell crosstalk, affect
fat catabolism in liver and adipose tissues [54,55]. This
effect was especially found to be important in animals
under high-fat diet. Thus, we may speculate that TTA
directed macrophage activation in Atlantic salmon fed
high fat diets could contribute to an improved metabolic
and inflammatory state.
Many studies have shown that the immune response is
necessary in order to evict an invading pathogen, how-
ever, an excessive inflammatory response can cause
unintended tissue damage, finally causing mortality [56].
Studies challenging Atlantic salmon with the viral
pathogen ISAV (infectious salmon anemia virus) have
shown that survival is not related to a strong innate
inflammatory response, but rather to an attenuated
innate and a stronger cell-mediated immune response
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ity as reported from TTA fed Atlantic salmons during
natural disease outbreaks [10,13] may partly result from
anti-inflammatory effects of TTA.
TTA has been reported to act as an agonist for all
PPAR subtypes in vitro [ 3 , 4 ] ,a n di ti sa s s u m e dt h a t
most physiological effects of TTA are mediated via acti-
vation of PPARs. In our experiment we found neither
significant transcriptional regulation of PPAR-a, b/δ
(represented on the Array, data not shown) nor PPAR-g,
(Figure 4). However, the fact that a large proportion of
the genes identified in our study have been reported to
be regulated by PPARs and that the list of DE genes
shows considerable overlap with the results from PPAR
stimulated murine macrophages K.O for PPAR-g or b/δ
[57] support our assumption that the ASK polarization
towards an alternative activated state may be induced
via activation of PPAR-g and b/δ by TTA.
Conclusions
The results presented in this study suggests that TTA
directs the macrophage-like cells towards an alternative
activated state which is indicated by a stimulated lipid
metabolism and attenuated inflammatory response.
Further the pattern of TTA regulated genes indicate
that the stimulation occurs via PPAR activation. The
effects confirm a function of TTA in Atlantic salmon
macrophages similar to those documented in mammals.
These findings supports that TTA modulates the
immune system of Atlantic salmon.
Methods
Cell Culture
The Atlantic salmon kidney cell line (ASK: ATCC: CRL-
2747) [14] was cultured and propagated at 20°C accord-
ing to standard cell culture procedures. Compared to
mammalian cell lines, fish cell lines thrive slowly [58],
so the ASK cells were studied for the respectively long
period of 7 days. The cells were seeded out at day 1 in
6 well format (density 5 × 10
4 cells/ml). On day 2-4 the
cells were pretreated with either TTA or control med-
ium. Day 5-7: cells were treated with either Control,
TTA, TTA+poly(I:C) or poly(I:C) medium.
Growth medium was L-15 (Invitrogen, MD, USA)
supplemented with 10% FBS (Invitrogen), 40μM b-Mer-
captoethanol and 50μg/ml Gentamycin. TTA medium
was prepared by dissolving TTA (ThiaMed-ica, Norway)
in 0.1 M NaOH at 80°C to a concentration of 100 mM,
this stock-solution was diluted to a final concentration
of 100μM in growth-medium [59]. Control-medium was
obtained by adding the same volume of 0.1 M NaOH as
used in the TTA medium to the growth medium. Poly
I:C was prepared by adding poly(I:C) (invitrogen) to a
final concentration of (50 μg/ml) to Control-medium.
TTA+poly(I:C) medium was obtained by adding poly(I:
C) to a final concentration of (50 μg/ml) to the TTA-
medium.
The cells were harvested on day 7 for RNA extraction.
An overview of the experimental design is given in
Table 1. The experiment was repeated four times with
four different passages (passages 6-9) from the cells.
RNA extraction
Total RNA was extracted using Qiazol (Qiagen, Halle,
Germany) and purified from the cells using column pur-
ification (Qiagen) according to the manufacturer’s
instructions. Traces of genomic DNA in the samples
were eliminated by on-column-DNase (Qiagen) diges-
tion. RNA concentrations were measured for all samples
using a NanoDrop 1000 Spectrophotometer. RNA qual-
ity for samples later used in the Microarray was deter-
mined using a Agilent 2100 Bioanalyzer (RNA 6000
NanoLabChip, Agilent, CA, USA). All samples had RIN
values ranging from 9.6 to 10, indicating high quality of
the RNA. Only individual RNA samples were used for
subsequent qRT-PCR and microarray experiments.
Quantitative RT-PCR
Single strand cDNA was reverse transcribed from 500
ng of total, DNase treated RNA using oligo dT primers
and the Taq Man reverse transcription Kit (Applied Bio-
systems, Tx, USA). qRT-PCR was performed in 96-well
optical plates on a Light-Cycler 480 (Roche, Switzer-
land). For the PCR reaction 2× SYBR green I master
Mix (Roche), 0.41 nM of each primer and the cDNA
template were mixed in a total reaction volume of 10μl.
Primer sequences are listed in Table 4. A three step
PCR protocol with 45 cycles (15 s 95°C, 15 s 60°C, 15 s
72°C) was used. To verify specific amplification a melt-
ing curve analysis step was done at the end of the pro-
gram. All samples were analyzed in duplicates and for
each measured gene a standard curve was produced
using a serial dilution from a pool of all cDNA samples.
The expression levels were calculated using the stan-
dard curve method (Applied Biosystems User Bulletin
2). Expression levels were standardized to the expression
of the housekeeping gene Elongation factor 1a (EF1a,
[60]), and log2FCs were calculated relative to the average
standardized sample that received control pretreatment
and control treatment. Significance was tested by con-
ducting a analysis of variance (ANOVA) test on the
log2FCs for each gene using the model:
yijk = μ + Pj + Tk + εijk (1)
Where yijk is the log2FC of the i
th sample that received
pretreatment j and treatment k. Pj is the effect of pre-
treatment j={contr, TTA}, Tk is the effect of treatment
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and ε is the error. A Tukey test was used subsequently
to identify differences within significant effects.
Microarray hybridization
The customized 4 × 44 K oligo (60-mer) Atlantic sal-
mon microarrays SIQ2.0 (Agilent) [18] was used in the
experiment. Unless otherwise stated all equipment and
reagents were from Agilent. Amplification and labeling
of 500 ng of total RNA and spike-ins for each sample
was performed using the Quick Amp Labeling Kit (One-
Color). After fragmentation of the Cy3 labeled cRNA,
the samples were hybridized to the microarray at 65°C
for 17 h. After hybridization the arrays were washed
with Gene Expression wash Buffer 1 and 2 and scanned
using a Agilent Microarray Scanner. All steps were con-
ducted according to the Agilent protocol (One-Color
Quick Amp Labeling, Version 5.7). Analysis of the mi-
croarray images was done in Agilent Feature Extraction
(Version 10.7.1.1) Softwa r eu s i n gt h eo n e - c o l o r
(GE1_107_Sep09) protocoll. Array quality was assessed
through Agilent control features and spike-in controls.
Data analysis
One array did not pass the quality checks and was
excluded from subsequent analysis. Normalization and
analysis of the data was done in R/Bioconductor [61]
using the Bioconductor package “limma” [19]. To gener-
ate the data-set, background corrected spot intensity sig-
nals (gProcessedSignal) were filtered according to the
following criteria provided by Feature Extraction: gIs-
Found, gIsPosAndSignif, gIsWellAboveBG and Control-
Type (a description of the feature results can be found
in the Feature Extraction Software Reference Guide). All
Control spots were removed from the data set. The
mean of the intensity signal for the duplicated features
was calculated and the data was subsequently normal-
ized by quantile normalization in order to adjust the
scale of intensities across arrays [62]. The data was then
log2 transformed and probe sets showing more than two
missing values were discarded from the data set, classi-
fying 12496 (59%) probe sets as present. Processed and
raw microarray data is publicly available at NCBI’s GEO
repository (http://www.ncbi.nlm.nih.gov/geo/, Acc.Nr:
GSE25328). A linear model (using zero intercept para-
meterization) was fitted to each probe set, where yijkl is
the log2 intensity of the i
th sample that received pre-
treatment j and treatment k. Pj is the effect of pretreat-
ment j ={ contr, TTA}, Tk is the effect of treatment k =
{contr, TTA, TTA+polyI:C, polyI:C}, Bl is the batch effect
l ={ 1,2}, μ is a constant and ε is the error.
yijkl = Pj + Tk + Bl + εijkl (2)
Subsequent to fitting the model to each probe set, a
number of specific contrasts of interest (listed in
Table 2) were extracted for each probe set. For a gra-
phical representation of the samples that were com-
pared by the contrasts see Additional file 2, Figure S1.
Improved variance estimates for the contrasts were
computed using empirical Bayes moderated t-statistics
from the “limma” package [63]. Before accounting for
multiple hypothesis testing, probe sets without anno-
tation were removed, reducing the data set to 10627
(50%) probe sets. Multiple hypothesis testing was
accounted for by controlling the false discovery rate
(FDR) [64] across all probes and contrasts simulta-
neously (using the method: global in the decideTests
function from the ‘limma” package). Probes were
declared significant when the q-value was ≤ 0.15 and
the log2FC ≥ 0.5.
Table 4 qRT-PCR primer sequences
ID/Gene.Acc.Nr. Gene Forward primer Reverse primer
AF321836 EF1a CACCACCGGCCATCTGATCTACAA TCAGCAGCCTCCTTCTCGAACTTC
KSS1708 ACADM GCCATCTCAGCCAACAGGAA GACAAGACCAGACCGCCAGT
GRASP209147493 S6A13 CCGTATGGGGGATGATGCTAA GGTAGTATGCTGACGACTGACACCT
S35506608 HSP70 AAGGCAAGATCAGCGAGGAG TGCCTGATCTCCACAGCAAC
GRASP209153907 ANGL4 AGGAGATGCAGCAGGAGAGG TTCTGAGCTTCCAGCATCCA
S32493348 TLR3 TCCAAGCCTGGTGACTCTCA CAGGTGGAGGACTCGTTAGGG
TC102663 UBA1 GCACTGTTTCCCCTCTGACC AGCAGTCTCGTGTTCCCACA
AF321836 TNFa (1+2) GCTTGTCTCTTGTTGCCACCA TGTGTGGGATGAGGATTTGGTT
AF088999 COX2 ACCTATGGGAACCGCAGGA GTGAAGTGCTGGGCGAAGA
EG929369 ARG1 AGCCATGCGTATCAGCCAA AAGGCGATCCACCTCAGTCA
AJ416951 PPARg CATTGTCAGCCTGTCCAGAC TTGCAGCCCTCACAGACATG
EF165028 IL10 ATGAGGCTAATGACGAGCTGGAGA GGTGTAGAATGCCTTCGTCCAACA
AY216594+AY216595 IFa (1+2) TGCAGTATGCAGAGCGTGTG TCTCCTCCCATCTGGTCCAG
SSU66477 MX TGATCGATAAAGTGACTGCATTCA TGAGACGAACTCCGCTTTTCA
AY617117 IL1b AGCAGGGTTCAGCAGTACAT CTCCATAGCCTCACTCATCA
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function topBlast from the program Blast2GO [65]. Full
length cDNA sequences of the probes have been com-
pared in a BlastX search against the Swissprot protein
database using an E-value cut-off of 10
-6 and the default
program settings. All plots were generated using the R
package “ggplot2” [66] and heatmaps were produced
using “lattice” [67].
Additional material
Additional file 1: Table S1. Table(.csv) of all probes. Column 1: Probe ID;
columns 2-6: log2FCs of the corresponding gene for the 5 different
contrasts preTTA vs. CTR, TTA vs. CTR, TTAIC vs. CTR, IC vs. CTR and IC vs.
TTAIC. Column 7-9: Gene annotation, gene symbol and e-value. Column
10-14: significance of the corresponding gene for the corresponding
contrast.
Additional file 2: Figure S1. Contrasts: A: Figure of the experimental
design (Table 1). Each of the eight nodes corresponds to a unique
combination of the two experimental factors Pretraetment and
Treatment. B: Figure displaying which combinations of Pretreatment and
Treatment were used in the contrast preTTA vs. CTR (RED nodes vs. BLUE
nodes). Figure for the remaining four contrasts are displayed; C: TTA vs.
CTR D: IC vs. CTR E: TTAIC vs. CTR F: IC vs. TTAIC. Comparison is RED nodes
vs. BLUE nodes, GREY nodes are not considered for the corresponding
contrast.
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